|
1
|
Val I and Almeida G: An overview of lichen
sclerosus. Clin Obstet Gynecol. 48:808–817. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Regauer S, Reich O and Beham-Schmid C:
Monoclonal gamma-T-cell receptor rearrangement in vulvar lichen
sclerosus and squamous cell carcinomas. Am J Pathol. 160:1035–1045.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Birenbaum DL and Young RC: High prevalence
of thyroid disease in patients with lichen sclerosus. J Reprod Med.
52:28–30. 2007.PubMed/NCBI
|
|
4
|
Hantschmann P, Sterzer S, Jeschke U and
Friese K: P53 expression in vulvar carcinoma, vulvar
intraepithelial neoplasia, squamous cell hyperplasia and lichen
sclerosus. Anticancer Res. 25:1739–1745. 2005.PubMed/NCBI
|
|
5
|
Pugliese JM, Morey AF and Peterson AC:
Lichen sclerosus: Review of the literature and current
recommendations for management. J Urol. 178:2268–2276. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fujimoto N, Asano C, Ono K and Tajima S:
Verruciform Xanthoma results from epidermal apoptosis with
galectin-7 overexpression. J Eur Acad Dermatol Venereol.
27:922–923. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cummings RD and Liu FT: Galectins. Cold
Spring Harbor Laboratory Press. 33:2009.
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nishioka M, Venkatesan N, Dessalle K,
Mogas A, Kyoh S, Lin TY, Nair P, Baglole CJ, Eidelman DH, Ludwig MS
and Hamid Q: Fibroblast-epithelial cell interactions drive
epithelial-mesenchymal transition differently in cells from normal
and COPD patients. Respir Res. 16:722015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Godoy CA, Teodoro WR, Velosa AP, Garippo
AL, Eher EM, Parra ER, Sotto MN and Capelozzi VL: Unusual
remodeling of the hyalinization band in vulval lichen sclerosus by
type V collagen and ECM 1 protein. Clinics (Sao Paulo). 70:356–362.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Di Lella S, Sundblad V, Cerliani JP,
Guardia CM, Estrin DA, Vasta GR and Rabinovich GA: When galectins
recognize glycans: From biochemistry to physiology and back again.
Biochemistry. 50:7842–7857. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Polyak K, Xia Y, Zweier JL, Kinzler KW and
Vogelstein B: A model for p53-induced apoptosis. Nature.
389:300–305. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barkan B, Cox AD and Kloog Y: Ras
inhibition boosts galectin-7 at the expense of galectin-1 to
sensitize cells to apoptosis. Oncotarget. 4:256–268. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee JS, Lee Y, Jeon B, Jeon Y, Yoo H and
Kim TY: EC-SOD induces apoptosis through COX-2 and galectin-7 in
the epidermis. J Dermatol Sci. 65:126–133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gendronneau G, Sanii S, Dang T, Deshayes
F, Delacour D, Pichard E, Advedissian T, Sidhu SS, Viguier M,
Magnaldo T and Poirier F: Overexpression of galectin-7 in mouse
epidermis leads to loss of cell junctions and defective skin
repair. PLoS One. 10:e01190312015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamaguchi T, Hiromasa K, Kabashima-Kubo R,
Yoshioka M and Nakamura M: Galectin-7, induced by cis-urocanic acid
and ultraviolet B irradiation, down-modulates cytokine production
by T lymphocytes. Exp Dermatol. 22:840–842. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yin GQ, Zhao SY, Guo SP, Zhao YH, Liu XC
and Jiang ZF: Galectin-7 is associated with bronchial epithelial
cell apoptosis in asthmatic children. Zhonghua Er Ke Za Zhi.
44:523–526. 2006.(In Chinese). PubMed/NCBI
|
|
18
|
Jiang Y, Tian R, Yu S, Zhao YI, Chen Y, Li
H, Qiao Y and Wu X: Clinical significance of galectin-7 in vulvar
squamous cell carcinoma. Oncol Lett. 10:3826–3831. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Grosset AA, Poirier F, Gaboury L and
St-Pierre Y: Galectin-7 expression potentiates her-2-positive
phenotype in breast cancer. PLoS One. 11:e01667312016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Higareda-Almaraz JC, Ruiz-Moreno JS,
Klimentova J, Barbieri D, Salvador-Gallego R, Ly R,
Valtierra-Gutierrez IA, Dinsart C, Rabinovich GA, Stulik J, et al:
Systems-level effects of ectopic galectin-7 reconstitution in
cervical cancer and its microenvironment. BMC Cancer. 16:6802016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim HJ, Jeon HK, Lee JK, Sung CO, Do IG,
Choi CH, Kim TJ, Kim BG, Bae DS and Lee JW: Clinical significance
of galectin-7 in epithelial ovarian cancer. Anticancer Res.
33:1555–1561. 2013.PubMed/NCBI
|
|
22
|
Demers M, Couillard J, Giglia-Mari G,
Magnaldo T and St-Pierre Y: Increased galectin-7 gene expression in
lymphoma cells is under the control of DNA methylation. Biochem
Biophys Res Commun. 387:425–429. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim SJ, Hwang JA, Ro JY, Lee YS and Chun
KH: Galectin-7 is epigenetically-regulated tumor suppressor in
gastric cancer. Oncotarget. 4:1461–1471. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rabinovich GA, Toscano MA, Jackson SS and
Vasta GR: Functions of cell surface galectin-glycoprotein lattices.
Curr Opin Struct Biol. 17:513–520. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Garner OB and Baum LG: Galectin-glycan
lattices regulate cell-surface glycoprotein organization and
signalling. Biochem Soc Trans. 36:1472–1477. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dange MC, Agarwal AK and Kalraiya RD:
Extracellular galectin-3 induces MMP9 expression by activating p38
MAPK pathway via lysosome-associated membrane protein-1 (LAMP1).
Mol Cell Biochem. 404:79–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Quan T, Little E, Quan H, Qin Z, Voorhees
JJ and Fisher GJ: Elevated matrix metalloproteinases and collagen
fragmentation in photodamaged human skin: Impact of altered
extracellular matrix microenvironment on dermal fibroblast
function. J Invest Dermatol. 133:1362–1366. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lochner K, Gaemlich A, Sudel KM, Südel KM,
Venzke K, Moll I, Knott A, Stäb F, Wenck H, Döring O, et al:
Expression of decorin and collagens I and III in different layers
of human skin in vivo: A laser capture microdissection study.
Biogerontology. 8:269–282. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Canady J, Karrer S, Fleck M and Bosserhoff
AK: Fibrosing connective tissue disorders of the skin: Molecular
similarities and distinctions. J Dermatol Sci. 70:151–158. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hashimoto S, Gon Y, Takeshita I, Matsumoto
K, Maruoka S and Horie T: Transforming growth Factor-beta1 induces
phenotypic modulation of human lung fibroblasts to myofibroblast
through a c-Jun-NH2-terminal kinase-dependent pathway. Am J Respir
Crit Care Med. 163:152–157. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rossi NE, Reiné J, Pineda-Lezamit M,
Pulgar M, Meza NW, Swamy M, Risueno R, Schamel WW, Bonay P,
Fernández-Malavé E and Regueiro JR: Differential antibody binding
to the surface alphabetaTCR.CD3 complex of CD4+ and CD8+ T
lymphocytes is conserved in mammals and associated with
differential glycosylation. Int Immunol. 20:1247–1258. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luo Z, Ji Y, Zhou H, Huang X, Fang J, Guo
H, Pan T and Chen ZK: Galectin-7 in cardiac allografts in mice:
Increased expression compared with isografts and localization in
infiltrating lymphocytes and vascular endothelial cells. Transplant
Proc. 45:630–634. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Terlou A, Santegoets LA, van der Meijden
WI, Heijmans-Antonissen C, Swagemakers SM, van der Spek PJ, Ewing
PC, van Beurden M, Helmerhorst TJ and Blok LJ: An autoimmune
phenotype in vulvar lichen sclerosus and lichen planus: A Th1
response and high levels of microRNA-155. J Invest Dermatol.
132:658–666. 2012. View Article : Google Scholar : PubMed/NCBI
|
